Rachna Khosla insider trades

Open-market stock purchases and sales by Rachna Khosla, SVP, Business Development at Amgen Inc, from SEC Form 4 filings since Nov 5, 2021.

Recent trades

DateStockTradeValue
Aug 13, 2026AMGN Amgen IncSold$521K
Aug 13, 2026AMGN Amgen IncBought (not open market)—
Aug 11, 2026AMGN Amgen IncSold$825K
May 7, 2026AMGN Amgen IncSold (not open market)$30.8K
May 6, 2026AMGN Amgen IncSold (not open market)$26K
May 5, 2026AMGN Amgen IncBought (not open market)—
May 5, 2026AMGN Amgen IncBought (not open market)$1.1M
May 2, 2026AMGN Amgen IncSold (not open market)$38.6K
May 2, 2026AMGN Amgen IncSold (not open market)$35.6K
Mar 16, 2026AMGN Amgen IncSold (not open market)$259K
Mar 3, 2026AMGN Amgen IncBought (not open market)—
Nov 12, 2025AMGN Amgen IncSold$299K
Nov 5, 2025AMGN Amgen IncSold (not open market)$67.1K

Companies traded

  • AMGN Amgen Inc: 5 sales, last Aug 13, 2026

Get free alerts when Rachna Khosla files a new trade →